# DarioHealth Corp.

Type: Company (DRIO)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/dariohealth-corp
Canonical HTML page: https://getfinancebrief.com/entity/dariohealth-corp

## Recent coverage (1 stories)

### Biofrontera and DarioHealth Pivot Toward Profitability in Q4 2025 Results
2026-03-19 17:05:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Biofrontera and DarioHealth reported Q4 2025 results on March 19, 2026, highlighting a strategic shift from aggressive growth to sustainable profitability. While Biofrontera focuses on expanding its dermatology market share with Ameluz, DarioHealth is leveraging its B2B2C model to drive high-margin digital health revenue.
Full story: https://getfinancebrief.com/story/biofrontera-dariohealth-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.